Short- and Long-term Outcome after Lung Resection for Invasive Pulmonary Aspergillosis

 

 Buy Article Permissions and Reprints All articles of this category

Abstract

Background: Lung resection for invasive pulmonary aspergillosis (IPA) is controversial. Neutropenia, thrombopenia and poor general condition may increase perioperative morbidity and mortality, and the redeeming benefit is questionable. Therefore we analyzed short- and long-term outcome after lung resection for IPA. Methods: 41 patients with hematological disease underwent lung resection for suspected IPA: lobectomy (23 patients), wedge-resection (16) and enucleation (2). Results: 4 (10 %) patients developed major complications: pleural aspergillosis, bronchial stump insufficiency, severe bleeding, ARDS. 11 (27 %) patients showed minor complications: pleural effusion (6), pneumothorax (2), seroma (2) and hematothorax (1). 30-day mortality was 10 % (4 of 41 patients): two died of bacterial septicemia, two of disseminated aspergillosis. One (2 %) death was possibly surgery-related. IPA was cleared in 87 % of patients, fungal relapse occurred in 4 (10 %) patients. Overall survival was 65 %, 58 % and 40 % at 6 months, 12 months and 5 years. Conclusion: Lung resection for IPA even in profound cytopenia is feasible with acceptable morbidity and mortality. Fungal infection can be cured in more than 80 % of patients. Long-term outcome can be achieved if the hematological disease is under control.

References

• 1 Jantunen E, Ruutu P, Piilonen A, Volin L, Parkkali T, Ruutu T. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients.  Bone Marrow Transplant. 2000;  26 759-762
  CrossrefPubMedGoogle Scholar
• 2 Saugier-Veber P, Devergie A, Sulahian P. et al . Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study.  Bone Marrow Transplant. 1993;  12 121-124
  PubMedGoogle Scholar
• 3 Baddley J W, Stroud T P, Salzman D, Pappas P G. Invasive mold infections in allogeneic bone marrow transplant recipients.  Clin Infect Dis. 2001;  32 1319-1324
  CrossrefPubMedGoogle Scholar
• 4 Denning D W, Stevens D A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.  Rev Invect Dis. 1990;  12 1147-1201
  CrossrefPubMedGoogle Scholar
• 5 Denning D W. Therapeutic outcome in invasive aspergillosis.  Clin Infect Dis. 1996;  23 608-615
  CrossrefPubMedGoogle Scholar
• 6 Lin S J, Schranz J, Teutsch S M. Aspergillosis case-fatality rate: systematic review of the literature.  Clin Infect Dis. 2001;  32 358-366
  CrossrefPubMedGoogle Scholar
• 7 Robinson L A, Reed E C, Galbraith T A, Alonso A, Moulton A L, Fleming W H. Pulmonary resection for invasive Aspergillus infections in immunocompromised patients.  J Thorac Cardiovasc Surg. 1995;  109 1182-1196
  PubMedGoogle Scholar
• 8 Caillot D, Casasnovas O, Bernard A. et al . Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.  J Clin Oncol. 1997;  15 139-147
  CrossrefPubMedGoogle Scholar
• 9 Baron O, Guillaume B, Moreau P. et al . Aggressive surgical management in localized pulmonary mycotic and nonmycotic infections for neutropenic patients with acute leukemia: report of eighteen cases.  J Thorac Cardiovasc Surg. 1998;  115 63-68
  CrossrefPubMedGoogle Scholar
• 10 Salerno C T, Ouyang D W, Pederson T S. et al . Surgical therapy for pulmonary aspergillosis in immunocompromised patients.  Ann Thorac Surg. 1998;  65 1415-1419
  CrossrefPubMedGoogle Scholar
• 11 Reichenberger F, Habicht J, Kaim A. et al . Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematological diseases.  Am J Respir Crit Care Med. 1998;  158 885-890
  PubMedGoogle Scholar
• 12 Habicht J M, Matt P, Passweg J R. et al . Invasive pulmonary fungal infection in hematological patients: is resection effective?.  Hematol J. 2001;  2 250-256
  CrossrefPubMedGoogle Scholar
• 13 Herbrecht R, Denning D W, Patterson T F. et al . Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.  N Engl J Med. 2002;  347 408-415
  CrossrefPubMedGoogle Scholar
• 14 Habicht J M, Passweg J, Kuhne T, Leibundgut K, Zerkowski H R. Successful local excision and long-term survival for invasive pulmonary aspergillosis during neutropenia after bone marrow transplantation.  J Thorac Cardiovasc Surg. 2000;  119 1286
  CrossrefPubMedGoogle Scholar
• 15 Yeghen Y, Kibbler C C, Prentice H G. et al . Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution.  Clin Infect Dis. 2000;  31 859-868
  CrossrefPubMedGoogle Scholar
• 16 Habicht J M, Reichenberger F, Gratwohl A. et al . Surgical aspects of resection for suspected invasive pulmonary aspergillosis in immunocompromised patients.  Ann Thorac Surg. 1999;  68 321-325
  CrossrefPubMedGoogle Scholar
• 17 Offner F, Cordonnier C, Ljungman P. et al . Impact of previous aspergillosis on the outcome of bone marrow transplantation.  Clin Infect Dis. 1998;  26 1098-1103
  PubMedGoogle Scholar

P. Matt MD 

Division of Cardio-Thoracic Surgery, Basel University Hospital, Kantonsspital

Spitalstraße 21

4031 Basel

Schweiz

Email: pmatt@uhbs.ch